Homospan Healthcare Profile
Key Indicators
- Authorised Capital ₹ 8.00 Cr
as on 29-12-2024
- Paid Up Capital ₹ 4.65 Cr
as on 29-12-2024
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 24.50 Cr
as on 29-12-2024
- Revenue %
(FY 2022)
- Profit -6585.43%
(FY 2022)
- Ebitda -424.96%
(FY 2022)
- Net Worth 45.10%
(FY 2022)
- Total Assets 135.26%
(FY 2022)
About Homospan Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 4.65 Cr.
The company currently has active open charges totaling ₹24.50 Cr.
Geetika Bajpai, Lokesh Singh, Ankit Awasthi, and Four other members serve as directors at the Company.
- CIN/LLPIN
U85100UP2018PTC107746
- Company No.
107746
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Sep 2018
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Homospan Healthcare?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Geetika Bajpai  | Director | 11-Sep-2018 | Current |
| Lokesh Singh | Director | 11-Sep-2018 | Current |
| Ankit Awasthi | Director | 11-Sep-2018 | Current |
| Amit Sen | Additional Director | 27-Sep-2021 | Current |
| Bulbull Sain | Additional Director | 27-Sep-2021 | Current |
| Ankur Awasthi | Director | 23-Oct-2020 | Current |
Financial Performance of Homospan Healthcare.
Homospan Healthcare Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 6585.43% decrease in profit. The company's net worth Soared by an impressive increase of 45.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Homospan Healthcare?
In 2021, Homospan Healthcare had a promoter holding of 30.19% and a public holding of 69.81%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
V-Bros Lifesciences Private LimitedActive 6 years 23 daysAmit Sen and Bulbull Sain are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 May 2023 | ₹2.50 Cr | Open |
Others Creation Date: 28 Sep 2021 | ₹20.00 Cr | Open |
Others Creation Date: 28 Sep 2021 | ₹2.00 Cr | Open |
How Many Employees Work at Homospan Healthcare?
Unlock and access historical data on people associated with Homospan Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Homospan Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Homospan Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
